ENTRY       D10633                      Drug
NAME        Finerenone (JAN/USAN/INN);
            Kerendia (TN)
PRODUCT     KERENDIA (Bayer Healthcare Pharmaceuticals)
FORMULA     C21H22N4O3
EXACT_MASS  378.1692
MOL_WEIGHT  378.4244
CLASS       Cardiovascular agent
             DG03231  Antihypertensive
              DG01676  Aldosterone antagonist
             DG01885  Potassium-sparing diuretic
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2190
            ATC code: C03DA05
            Product: D10633<JP/US>
EFFICACY    Diuretic, Aldosterone antagonist
  DISEASE   Chronic kidney disease associated with type 2 diabetes [DS:H01456]
COMMENT     Treatment of chronic heart failure and diabetic nephropathy
TARGET      NR3C2 (MR) [HSA:4306] [KO:K08555]
  PATHWAY   hsa04960(4306)  Aldosterone-regulated sodium reabsorption
METABOLISM  Enzyme: CYP3A4 [HSA:1576]; CYP2C8 [HSA:1558]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C03 DIURETICS
               C03D ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS
                C03DA Aldosterone antagonists
                 C03DA05 Finerenone
                  D10633  Finerenone (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Mineralocorticoid Receptor Antagonist
               Finerenone
                D10633  Finerenone (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D10633  Finerenone (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG03231  Antihypertensive
               DG01676  Aldosterone antagonist
                D10633  Finerenone
              DG01885  Potassium-sparing diuretic
               D10633  Finerenone
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               D10633  Finerenone
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10633  Finerenone
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01676  Aldosterone antagonist
               D10633  Finerenone
              DG03231  Antihypertensive
               D10633  Finerenone
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                NR3C2 (MR)
                 D10633  Finerenone (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10633
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10633
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10633
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10633
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10633
DBLINKS     CAS: 1050477-31-0
            PubChem: 254741594
ATOM        28
            1   C8x C    15.0895  -12.3379
            2   N5x N    15.0895  -13.7090
            3   C8y C    16.2767  -14.3945
            4   C8y C    17.4642  -13.7090
            5   C8y C    17.4642  -12.3379
            6   C8y C    16.2767  -11.6524
            7   C1y C    18.6515  -14.3945
            8   C2y C    19.8388  -13.7090
            9   C2y C    19.8388  -12.3379
            10  N1x N    18.6515  -11.6524
            11  C1a C    16.2767  -10.2814
            12  C1a C    21.0262  -11.6524
            13  O2a O    16.2767  -15.7655
            14  C5a C    21.0262  -14.3945
            15  N1a N    22.2135  -13.7090
            16  O5a O    21.0262  -15.6969
            17  C8y C    18.6515  -16.5880
            18  C8x C    17.4662  -17.2724
            19  C8x C    17.4662  -18.6434
            20  C8y C    18.6534  -19.3289
            21  C8x C    19.8388  -18.6446
            22  C8y C    19.8388  -17.2736
            23  O2a O    21.0260  -16.6687
            24  C1a C    22.2599  -17.3078
            25  C3b C    18.6534  -20.7000
            26  N3a N    18.6534  -22.0710
            27  C1b C    15.0960  -16.4473
            28  C1a C    15.0960  -17.8473
BOND        30
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11    5  10 1
            12    6  11 1
            13    9  12 1
            14    3  13 1
            15    8  14 1
            16   14  15 1
            17   14  16 2
            18    7  17 1 #Up
            19   17  18 2
            20   18  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   17  22 1
            25   22  23 1
            26   23  24 1
            27   20  25 1
            28   25  26 3
            29   13  27 1
            30   27  28 1
///
